Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (453)	12/9/1999 8:13:00 PM
From: michael modeme	Read Replies (2) \| Respond to of 3044

Well, I work in Genomics and I'm pretty sure that the amount of products that will be produced from genomic/bioinformatic research is tremendous. The stuff we can do right now is absolutely amazing. Right now, (given enough money) I could, by myself, develop a gene chip assay for chrom 22 in humans, look at expression levels among different genotypes, and do statistical analyses for the correlation between gene regulation and diseases specific to the 22nd chrom. And I am just one person with limited experience.....MLNM is much more capable than myself. Cheers